BD second quarter revenues increase 3.

BD second quarter revenues increase 3.6 percent to $1.991 billion BD , a respected global medical technology organization, today reported quarterly revenues of $1 .991 billion for the next fiscal one fourth ended March 31, 2012, representing a rise of 3.6 % from the prior-year period, or 4.6 % on a foreign currency-neutral basis. We posted solid revenue development led by our BD BD and Medical Diagnostics segments, despite continuing difficulties in the U.S. Inside our BD Biosciences segment, stated Vincent A. Forlenza, CEO and President. We remain focused on our strategy of trading and innovating for development, both organically and through acquisitions such as for example KIESTRA Lab Automation.

It’ll make a significant difference in your hearing and in yourself. BHI has released a comprehensive consumer guidebook entitled, Your Guidebook to purchasing Hearing Aids. The rules give self-confidence to first-time hearing help buyers by providing an in depth, step-by-step description of what things to expect, ask, to check out when choosing and visiting a hearing healthcare purchasing and professional a hearing aid. BHI has published also, Your Guidebook to Financial Assistance for Hearing Helps, the first comprehensive guidebook on how people can buy financial assist with purchase hearing aids.. BHI warns customers about inherent risks associated with hearing devices The Better Hearing Institute is warning consumers of the inherent risks connected with purchasing over-the-counter, one-size-fits-all hearing aids rather than consulting a hearing doctor.

Other entries from category "clinical":

Random entries